FOI2021/00428: Drug SNG001
Case reference FOI2021/00428
Published 2 December 2021
Request
Request Received: 16 September 2021
I would like information on a drug SNG001 made by a company called Synairgen. I was surprised to see that this hasn't been included on your website despite applications to be included.
I would therefore like any information why the UK COVID-19 Therapeutics Advisory Panel (UK-CTAP) hasn't endorsed inhaled interferon beta drug (SNG001) and the reasons for the rejected.
Response
Response Sent: 27 September 2021
Full details of this response are provided in the attached document.
Documents
This is UK Research and Innovation's response to a freedom of information (FOI) or environmental information regulations (EIR) request.
You can browse our other responses or make a new FOI request.